搜索
Title:ActiveingredientcombinationsofpolyhexamethylenebiguanidinehydrochlorideanddistearyldimethylammoniumchlorideandpreparationscomprisingsaidactiveingredientcombinationsDocumentTypeandNumber:UnitedStatesPatentApplication20060018847KindCode:A1Abstract:Theinventionisanactiveingredientcombinationcomprisingpolyhexamethylenebiguanidinehydrochlorideanddistearyldimethylammoniumchlorideandacosmeticordermatologicalformulationcomprisingpolyhexamethylenebiguanidinehydrochlorideanddistearyldimethylammoniumchloride.Theinventionalsoincludesmethodsoffightingorpreventingdermatologicalharmcomprisingapplyingtotheskinacosmeticordermatologicalformulationcomprisingpolyhexamethylenebiguanidinehydrochlorideanddistearyldimethylammoniumchloride.Theinventionalsoincludesmethodsofpreventingdecayoforganicsubstancesinaformulation,comprisingaddingtosaidformulationpolyhexamethylenebiguanidinehydrochlorideanddistearyidimethylammoniumchloride.AdsbyGoogleGlycidylmethacrylateMethacrylicacidoracrylicacidwithavarietyofdifferentalcoholwww.nofamerica.comAntibioticResistanceProtectionAgainstCatheter-RelatedBloodstreamInfections.ReadMore..www.cookmedical.com8MGuanidineSolutionHighpurity8MGuanidine-HClforproteinsolubilization&refolding.www.piercenet.comLotrylResinsArkemamanufacturesLotrylResinsEBAandEMAcopolymerswww.arkema-inc.comStaphAureusCountsReduceStaphAureusCounts,WipersImproveIPAContactTimes.SeeHow!www.Foamtecintlwcc.comInventors:Kroepke,Rainer(Schenefeld,DE)Zelle,Dagmar(Bliedersdorf,DE)Filbry,Alexander(Hamburg,DE)Hamer,Gunhild(Hamburg,DE)PlaqueIt!ApplicationNumber:11/090693PublicationDate:01/26/2006FilingDate:03/25/2005ViewPatentImages:ImagesareavailableinPDFformwhenloggedin.ToviewPDFs,LoginorCreateAccount(Free!)ExportCitation:ClickforautomaticbibliographygenerationAssignee:BeiersdorfAGPrimaryClass:424/78.270OtherClasses:424/59,514/635,514/643InternationalClasses:A61K7/42;A61K31/155;A61K31/14Attorney,AgentorFirm:ALSTON&BIRDLLP;BANKOFAMERICAPLAZA(101SOUTHTRYONSTREET,SUITE4000,CHARLOTTE,NC,28280-4000,US)Claims:Thatwhichisclaimed:1.Anactiveagentcombination,comprisingpolyhexamethylenebiguanidinehydrochlorideanddistearyldimethylammoniumchloride.2.Acosmeticordermatologicalformulation,comprisingpolyhexamethylenebiguanidinehydrochlorideanddistearyldimethylammoniumchloride.3.Thecosmeticordermatologicalformulationasclaimedinclaim2,furthercomprisingatleastoneantioxidant.4.Thecosmeticordermatologicalformulationasclaimedinclaim2,furthercomprisingatleastoneUVfiltersubstance.5.Thecosmeticordermatologicalformulationasclaimedinclaim2,whereinsaidformulationisintheformofanemulsion.6.Thecosmeticordermatologicalformulationasclaimedinclaim2,whereinsaidformulationisintheformofanoil-in-wateremulsion.7.Thecosmeticordermatologicalformulationasclaimedinclaim2,whereinsaidformulationisintheformofawater-in-oilemulsion.8.Thecosmeticordermatologicalformulationasclaimedinclaim2,comprisingfrom0.01to20%byweightintotalofthecombinationofpolyhexamethylenebiguanidinehydrochlorideanddistearyldimethylammoniumchloride,basedonthetotalweightoftheformulation.9.Thecosmeticordermatologicalformulationasclaimedinclaim8,comprisingfrom0.02to5%byweightintotalofthecombinationofpolyhexamethylenebiguanidinehydrochlorideanddistearyidimethylammoniumchloride,basedonthetotalweightoftheformulation.10.Thecosmeticordermatologicalformulationasclaimedinclaim9,comprisingfrom0.05to3%byweightintotalofthecombinationofpolyhexamethylenebiguanidinehydrochlorideanddistearyidimethylammoniumchloride,basedonthetotalweightoftheformulation.11.Amethodofpreventingthegrowthofbacteria,mycobionts,andviruses,comprisingapplyinganactiveagentcombinationcomprisingpolyhexamethylenebiguanidinehydrochlorideanddistearyldimethylammoniumchloride.12.Amethodoffightingorpreventingdermatologicalharm,comprisingapplyingtotheskinacosmeticordermatologicalformulationcomprisingpolyhexamethylenebiguanidinehydrochlorideanddistearyldimethylammoniumchloride.13.Themethodasclaimedinclaim12,whereinsaidformulationcomprisesfrom0.01to20%byweightintotalofthecombinationofpolyhexamethylenebiguanidinehydrochlorideanddistearyldimethylammoniumchloride,basedonthetotalweightoftheformulation.14.Themethodasclaimedinclaim12,whereinsaidformulationcomprisesfrom0.02to5%byweightintotalofthecombinationofpolyhexamethylenebiguanidinehydrochlorideanddistearyldimethylammoniumchloride,basedonthetotalweightoftheformulation.15.Themethodasclaimedinclaim12,whereinsaidformulationcomprisesfrom0.05to3%byweightintotalofthecombinationofpolyhexamethylenebiguanidinehydrochlorideanddistearyldimethylammoniumchloride,basedonthetotalweightoftheformulation.16.Themethodasclaimedinclaim12,forpreventingorimprovingneurodermatitis.17.Themethodasclaimedinclaim12,forpreventingthegrowthoforkillingStaphylococcusaureus.18.Amethodofpreventingdecayoforganicsubstancesinaformulation,comprisingaddingtosaidformulationpolyhexamethylenebiguanidinehydrochlorideanddistearyldimethylammoniumchloride.19.Themethodasclaimedinclaim18,whereinsaidformulationcomprisesfrom0.01to20%byweightintotalofthecombinationofpol